PATENT CLAIM ANALYSIS

Application Number: 15767795
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "248000"]

Abstract:
The present invention provides compounds of Formula I: wherein Y, AA, W, R 3′  R 2 , R 4 , R 5 , R 6 , R 7 , X 1 , X 2 , X 3 , X 4  and X 5  are as defined herein, or a stereoisomer, tautomer, pharmaceutically acceptable salt, prodrug or esters or solvate form thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of platelet aggregation and thus can be used as medicaments for treating or preventing thromboembolic disorders.

Claim (Index 16):
A method for the treatment of a thromboembolic disorder or the primary or secondary prophylaxis of a thromboembolic disorder, which comprises the steps of administering to a patient in need thereof a therapeutically effective amount of a compound as defined in  claim 1 , or stereoisomers, tautomers, pharmaceutically acceptable salts, or solvates thereof, wherein the thromboembolic disorder is selected from the group consisting of arterial cardiovascular thromboembolic disorders, venous cardiovascular thromboembolic disorders, cerebrovascular thromboembolic disorders, and thromboembolic disorders in the chambers of the heart or in the peripheral circulation.

Metadata:
- Claim Count in Document: 22.0
- Percentile: 91.0
- Lexical Diversity: 1.71186
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15549307', '15549257', '14396831', '15593534', '14396807']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8464551947838453
- 35 USC 102 Novelty (BERT): 0.5515709663283156
- Combined Prediction Score: 0.8169667719382924
- Mean Citation Score: 404.92014600000016
- Max Citation Score: 412.2366
- Similarity Product: 405.6373856342197

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test